Litvinov R.I.; Evtugina N.G.; Peshkova A.D.; Safiullina S.I.; Andrianova I.A.; Khabirova A.I.; Nagaswami C.; Khismatullin R.R.; Sannikova S.S.; Weisel J.W.
(2021)
To reveal if coagulopathies relate to the course of COVID-19, we examined 255 patients with moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs. Coagulopathy manifested predominantly as ...